Centella is widely used because it is effective at low percentages
Diabetes guidelines recommend these GLP-1 RAs as pharmacologic agents in patients with ASCVD or with high-risk indicators for cardiovascular disease
A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes
That level of weight loss produces meaningful improvements in blood pressure, blood sugar control, lipid profiles, and overall cardiovascular risk markers
The legal requirements are clear, enforcement is active and aggressive, and the consequences of non-compliance are severe
Approval of tirzepatide (brand name Mounjaro/Zepbound), an even more efficacious medication, soon followed in 2023